Benefits of a Pediatric Antimicrobial Stewardship Program in Antimicrobial Use and Quality of Prescriptions in a Referral Children's Hospital

J Pediatr. 2020 Oct:225:222-230.e1. doi: 10.1016/j.jpeds.2020.06.008. Epub 2020 Jun 6.

Abstract

Objectives: To evaluate the results of the first 24 months of a postprescription review with feedback-based antimicrobial stewardship program in a European referral children's hospital.

Study design: We performed a pre-post study comparing antimicrobial use between the control (2015-2016) and the intervention periods (2017-2018) expressed in days of therapy/100 days present. Quality of prescriptions was evaluated by quarterly cross-sectional point-prevalence surveys. Length of stay, readmission rates, in-hospital mortality rates, cost of systemic antimicrobial agents, and antimicrobial resistance rates were included as complementary outcomes.

Results: Total antimicrobial use and antibacterial use significantly decreased during the intervention period (P = .002 and P = .001 respectively), and total antifungal use remained stable. A significant decline in parenteral antimicrobial use was also observed (P < .001). In 8 quarterly point-prevalence surveys (938 prescriptions evaluated), the mean prevalence of use of any antimicrobial among inpatients was 39%. An increasing trend in the rate of optimal prescriptions was observed after the first point-prevalence survey (P = .0898). Nonoptimal prescriptions were more common in surgical than in medical departments, in antibacterial prescriptions with prophylactic intention, and in empirical more than in targeted treatments. No significant differences were observed in terms of mortality or readmission rates. Only minor changes in antimicrobial resistance rates were noted.

Conclusions: Our antimicrobial stewardship program safely decreased antimicrobial use and expenditure, and a trend toward improvement in quality of prescription was also observed.

Keywords: antibiotic; antifungal; antimicrobial resistance; pediatrics; quality indicators.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Antifungal Agents / administration & dosage
  • Antimicrobial Stewardship / methods*
  • Cross-Sectional Studies
  • Drug Prescriptions / statistics & numerical data*
  • Hospitals, Pediatric / statistics & numerical data
  • Humans
  • Interrupted Time Series Analysis
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Program Evaluation
  • Spain

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents